Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphoma, High-grade”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT00659035
What this trial is testing

Use of Driving Tests to Evaluate Patient Performance on Oral Opioids

Who this might be right for
Chronic Pain
Asokumar Buvanendran 450
Testing effectiveness (Phase 2)Active Not RecruitingNCT05507541
What this trial is testing

TTI-622 in Combination With Pembrolizumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Recurrent ALK Positive Large B-Cell LymphomaRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation+25 more
Mayo Clinic 10
Large-scale testing (Phase 3)Ended earlyNCT01163253
What this trial is testing

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 2,867
Testing effectiveness (Phase 2)Study completedNCT00064311
What this trial is testing

Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
National Institutes of Health Clinical Center (CC)
Testing effectiveness (Phase 2)Looking for participantsNCT06649812
What this trial is testing

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

Who this might be right for
High Grade B-Cell Lymphoma With MYC and BCL6 RearrangementsRecurrent Diffuse Large B-Cell LymphomaRecurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type+12 more
National Cancer Institute (NCI)
Not applicableApproved For MarketingNCT03153462
What this trial is testing

Axicabtagene Ciloleucel Expanded Access Study

Who this might be right for
Relapsed/Refractory Diffuse Large B Cell LymphomaRelapsed/Refractory Primary Mediastinal B Cell LymphomaRelapsed/Refractory Transformed Follicular Lymphoma+1 more
Kite, A Gilead Company
Testing effectiveness (Phase 2)Study completedNCT00596804
What this trial is testing

Safety Study of Different Doses of hA20 (Veltuzumab) in CD20+ Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's LymphomaLymphoma, DiffuseLymphoma, Diffuse, Mixed Lymphocytic-Histiocytic
Gilead Sciences 39
Not applicableNot Yet RecruitingNCT06958770
What this trial is testing

Combining Electrical Impedance Tomography and Thoracic Ultrasound Toinvestigate Dynamic Changes

Who this might be right for
ARDS (Moderate or Severe)
National Taiwan University Hospital 50
Testing effectiveness (Phase 2)Study completedNCT04358406
What this trial is testing

Rhu-pGSN for Severe Covid-19 Pneumonia

Who this might be right for
Sars-CoV2
BioAegis Therapeutics Inc. 64
Testing effectiveness (Phase 2)Study completedNCT05962606
What this trial is testing

Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia.

Who this might be right for
Community-acquired Pneumonia
Aptarion Biotech AG 150
Testing effectiveness (Phase 2)Ended earlyNCT03738423
What this trial is testing

Efficacy, Safety, and Pharmacokinetic Profiles of REGN3500 Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Regeneron Pharmaceuticals 129
Not applicableLooking for participantsNCT07176624
What this trial is testing

The PRE-VAIL Study

Who this might be right for
ARDS (Moderate or Severe)Prone PositionEnteral Nutrition Feeding+1 more
The First Hospital of Jilin University 259
Testing effectiveness (Phase 2)Study completedNCT00618722
What this trial is testing

Phase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat

Who this might be right for
Moderate or Severe Submental Fullness
Kythera Biopharmaceuticals 85
Not applicableUnknownNCT03020394
What this trial is testing

Respiratory Support in Severe Chronic Obstructive Pulmonary Disease Exacerbation

Who this might be right for
COPD Exacerbation
China-Japan Friendship Hospital 208
Testing effectiveness (Phase 2)Ended earlyNCT02882087
What this trial is testing

The Efficacy and Safety of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Inadequate Response to TNF-α Antagonists Due to Treat Moderate and Severe Rheumatoid Arthritis

Who this might be right for
Moderate and Severe Rheumatoid Arthritis
RemeGen Co., Ltd. 60
Large-scale testing (Phase 3)Study completedNCT02007434
What this trial is testing

Patient Experience Study of Deoxycholic Acid Injection

Who this might be right for
Moderate or Severe Submental Fullness
Kythera Biopharmaceuticals 84
Not applicableActive Not RecruitingNCT04921787
What this trial is testing

EXHIT ENTRE Implementation Trial of High Intensity Versus Low Intensity Strategy

Who this might be right for
Substance Use DisordersOpioid Use Disorder, SevereOpioid Use Disorder, Moderate
Gavin Bart 24
Testing effectiveness (Phase 2)Looking for participantsNCT05908409
What this trial is testing

IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies

Who this might be right for
Multiple Myeloma (MM)Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedDouble Hit Lymphoma+3 more
IDP Discovery Pharma S.L. 37
Testing effectiveness (Phase 2)Study completedNCT00004898
What this trial is testing

Radiation Therapy and Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With High-Grade Lymphoma or Acute Lymphoblastic Leukemia

Who this might be right for
LeukemiaLymphoma
Northwestern University 6
Testing effectiveness (Phase 2)Study completedNCT03113422
What this trial is testing

Phase II Venetoclax, Obinutuzumab and Bendamustine in High Tumor Burden Follicular Lymphoma as Front Line Therapy

Who this might be right for
Follicular LymphomaNon-Hodgkin's Lymphoma FollicularNon-Hodgkin's Lymphoma, Adult High Grade
PrECOG, LLC. 56
Next Page
120